Manuscript Submission/Review Call for Reviewers Articles in Press Search Past Issues Current Issue Journal Home Editorial Office Editorial Board Cleft Palate-Cranofacial Foundation Contact Us Sponsors Cleft Palate-Cranofacial Foundation Editorial Office ACAP Homepage Cleft Palate-Cranofacial Foundation
[Full-text Article] [PDF Version]
[PubMed Citation] [Related Articles in PubMed]


doi: 10.1597/03-141.1
The Cleft Palate-Craniofacial Journal: Vol. 42, No. 4, pp. 344–348.

Treatment of Osseous Cleft Palate Defects: A Preliminary Evaluation of Novel Treatment Modalities

Micha Peled, M.D., D.M.D.
Dror Aizenbud, D.M.D., M.Sc.
Jacob Horwitz, D.M.D.
Eli E. Machtei, D.M.D.

Dr. Peled is Clinical Senior Lecturer, Faculty of Medicine–Technion, Haifa, Israel, and Chairman, Department of Maxillofacial Surgery, Rambam Medical Center, Haifa, Israel. Dr. Aizenbud is Head, Cleft Palate Unit, Rambam Medical Center, Haifa, Israel, and Adjunct Lecturer, Faculty of Medicine–Technion, Haifa, Israel. Dr. Horwitz is with the Unit of Periodontology, Rambam Medical Center, Haifa, Israel. Dr. Machtei is Clinical Associate Professor, Faculty of Medicine–Technion, Haifa, Israel, and Head, Unit of Periodontology, Rambam Medical Center, Haifa, Israel

Submitted October 2003; Accepted June 2004.

Objective: To compare the use of autogenous iliac bone graft (ABG) alone with nonresorbable expanded polytetrafluoroethylene Gore-Tex TR membrane (GTM) and with ABG plus resorbable Resolut XT membrane barriers for the secondary closure of alveolar cleft defects.

Study Design: Fifteen patients aged 9 to 17 years with unilateral cleft palate were included in this study. All patients had primary closure of the soft tissues at infancy. Presurgical orthodontics and scaling preceded the surgery. The patients were randomized to one of three surgical treatment groups: (1) ABG, (2) GTM, or (3) autogenous bone plus resorbable membrane (ABM). Periapical radiographs were taken pretreatment and 2 to 6 years later and were used to measure changes in size (linear and area) of the osseous defect.

Results: Significant decreases were observed in mean initial defect width (9.8 to 6.7 mm; p = .0263), mean initial defect height (20.7 to 15.1 mm), and overall mean defect size (223.6 to 143.9 mm2). Greater improvement in mean defect width was observed for the ABM group (6.42 mm) compared with the ABG (1.22 mm) and GTM (1.38 mm) groups. The reduction in overall mean defect size was significantly greater in the ABM group (177 mm2) compared with the GTM (20.51 mm2) and ABG (41.69 mm2) groups.

Conclusion: Guided bone regeneration was found potentially useful for the treatment of osseous cleft palate defects. The combined approach yielded significantly greater defect fill. If further substantiated in larger independent studies, the adjunctive use of barrier membranes could improve the management of secondary closure of cleft palate defects.

KEY WORDS:alveolar cleft defects, iliac bone graft, membrane barrier, secondary cleft closure


© 2005, The American Cleft Palate-Craniofacial Association